Isodiol International Inc Delivers an Update on the Delay in Filing Its Audited Economic Statements

[ad_1]

Aug 12, 2019 – Vancouver, BC –  Isodiol International Inc. (CSE: ISOL) (OTCQB:ISOLF)
(FSE: LB6B.F)(the “Company” or “Isodiol”), provides an update on the delay on the filing of its
audited annual monetary statements, connected management’s discussion and evaluation and
supporting officer certificates for the monetary year ended March 31, 2019 (the “Filings”).
The Firm obtained a management cease trade order dated July 30, 2019 from the relevant
securities regulators as contemplated by National Policy 12-203 Management Cease Trade
Orders of the Canadian Securities Administrators
The delay of the Filings resulted from delays in the Firm getting access to accounting
information and facts following dispositions of subsidiaries more than which the Firm no longer has
management influence. The Firm notes the audit is practically total and continues to
count on to file the Filings on or just before August 16, 2019.
The Firm will comply with the needs of the option information and facts recommendations set
out in the National Policy. The Firm is not topic to any insolvency proceedings.

Stick to Our Corporate Updates On Facebook at www.facebook.com/IsodiolInternationalInc/,
on Twitter @Isodiolintlinc, and on Instagram @isodiol.

About Isodiol International Inc.
Isodiol International Inc.is focused on the nutritional overall health added benefits that are derived from hemp
and is a solution improvement, sales, advertising and marketing and distribution organization of hemp-primarily based
Customer Packaged Goods (CPG) and options. Isodiol has commercialized a 99%+ pure,
naturally isolated CBD, such as micro-encapsulations, and nano-technologies for top quality
consumable and topical skin care items. Isodiol’s development approach involves the improvement
of more than-the-counter and pharmaceutical drugs and continued international expansion into Latin
America, Asia, and Europe.

ON BEHALF OF THE BOARD
Marcos Agramont, CEO &amp Director

INVESTOR RELATIONS:
[email protected]
604-409-4409

MEDIA Get in touch with:
Christopher Hussey
[email protected]

The CSE has not reviewed, authorized or disapproved the content material of this press release.

Forward-Hunting Data: This news release includes “forward-seeking information” inside
the which means of applicable securities laws relating to statements relating to the Company’s
enterprise, proposed arrangement with creditors, items and future the Company’s enterprise, its
solution offerings and plans for sales and advertising and marketing. Though the Firm believes that the
expectations reflected in the forward-seeking information and facts are affordable, there can be no
assurance that such expectations will prove to be right. Readers are cautioned not to location
undue reliance on forward-seeking information and facts. Such forward-seeking statements are topic to
dangers and uncertainties that may perhaps trigger actual outcomes, efficiency and developments to differ
materially from these contemplated by these statements based on, amongst other points, the
dangers that the Company’s items and program will differ from these stated in this news release and
the Firm may perhaps not be in a position to carry out its enterprise plans as anticipated. Except as necessary by
law, the Firm expressly disclaims any obligation and does not intend, to update any forward seeking
statements or forward-seeking information and facts in this news release. Though the Firm
believes that the expectations reflected in the forward-seeking information and facts are affordable, there
can be no assurance that such expectations will prove to be right and tends to make no reference to
profitability primarily based on sales reported. The statements in this news release are produced as of the date
of this release.

The CSE has not reviewed, authorized or disapproved the content material of this press release.



[ad_2]

Latest posts